Accordingly, glutamine-supplemented mice had increased percentages and numbers of intratumoral CD8+ T cells that expressed IFNγ, TNF or granzyme B (Fig. 1j), and more readily cleared tumour antigen-pulsed splenocytes in an in vivo killing assay24 (Extended Data Fig. 1j). The gene discussed is CD8A; the disease is neoplasm.